Snowball logo
logo
PTCT_logo

PTC Therapeutics, Inc

PTCT NASDAQ
$73.57+$0.56  (0.77%)

Frequently asked questions

What sector does PTC Therapeutics, Inc (PTCT) operate in?

PTC Therapeutics, Inc belongs to the Healthcare sector and operates in the Biotechnology industry.

What is PTC Therapeutics, Inc (PTCT) current stock price?

As of the latest data, PTC Therapeutics, Inc stock price is $73.57, with a previous close of $73.01. PTC Therapeutics, Inc gained $0.56 in the last trading session, representing a 0.77% increase.

What is PTC Therapeutics, Inc (PTCT) current market capitalization?

PTC Therapeutics, Inc market cap is approximately 5.91 billion.

What is PTC Therapeutics, Inc (PTCT) Earnings Per Share (EPS)?

The trailing EPS is $8.60, and the forward EPS is $3.10.

What is PTC Therapeutics, Inc (PTCT) Price-to-Earnings (P/E) ratio?

PTC Therapeutics, Inc current P/E ratio is 8.55, with a forward P/E of 23.77.

What is PTC Therapeutics, Inc (PTCT) EBITDA?

PTC Therapeutics, Inc EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) is -68.72 million.

Does PTC Therapeutics, Inc (PTCT) pay dividends?

No. PTC Therapeutics, Inc does not pay a dividend.

How did PTC Therapeutics, Inc (PTCT) perform in its most recent earnings report?

In the last report (December 31, 2025), PTC Therapeutics, Inc posted an EPS surprise of -598.1% and a revenue surprise of -91.08%.

When is PTC Therapeutics, Inc (PTCT) next earnings report?

PTC Therapeutics, Inc is expected to release its next earnings report on March 31, 2026.

What is PTC Therapeutics, Inc (PTCT) beta (volatility) score?

PTC Therapeutics, Inc has a beta of 0.487, indicating lower volatility than the overall market.